Birth prevalence of congenital heart disease: A cross-sectional observational study from North India.
Anita Saxena, Anurag Mehta, Mamta Sharma...
https://pubmed.ncbi.nlm.nih.gov/27625516Actively Recruiting
Age: 1Day - 16Years
All Genders
ID06492473
Clinical Evaluation Of Ventricular Septal Defect (VSD) in Children at Sohag University Hospital
Led by Sohag University · Updated on 2024-07-09
100
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Ventricular septal defect (VSD) is one of the most common significant congenital heart defects, accounting for up to 40% of all cardiac abnormalities. It can occur alone or as part of more complex heart malformations such as tetralogy of Fallot, double-outlet right ventricle, transposition of the great vessels, aortic coarctation or interruption, and truncus arteriosus. This observational study aims to clinically evaluate VSD in children to better understand its characteristics and progression. The study involves using echocardiography (ECHO) to determine the type and size of the ventricular septal defect. Children diagnosed with isolated VSD or VSD accompanied by other cardiac anomalies will be observed. The primary outcome measure is the size of the VSD assessed over a 12-month period. Participants will be children from birth up to 16 years old, inclusive of both genders. The evaluation includes echocardiographic imaging to monitor the VSD size and type. Researchers will collect and analyze this data to track the heart defect's status. The study participation will last for at least 12 months to observe changes in the VSD size over time.
CONDITIONS
Brief Title
Clinical Evaluation Of Ventricular Septal Defect (VSD) In Children at Sohag Univesity Hospital
Who Can Participate
Age: 1Day - 16Years
All Genders
Eligibility Criteria
You may qualify if you...
- Children from birth up to 16 years old of both genders
- Diagnosed with isolated ventricular septal defect (VSD) or VSD with other cardiac anomalies
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Implementation
Duration - Up to 12 months
Participants undergo echocardiogram (ECHO) to evaluate the type and size of ventricular septal defect (VSD).
Trial Site Locations
Total: 1 location
1
Sohag University hospitals
Sohag, Egypt
Actively Recruiting
Loading map...
Research Team
A
amany S Thabit, Resident
M
mohamed A mohamed, Professor
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
Classification of ventricular septal defects.
B Soto, A E Becker, A J Moulaert...
https://pubmed.ncbi.nlm.nih.gov/7437181Ventricular septal defects: a surgical viewpoint.
B Soto, R Ceballos, J W Kirklin
https://pubmed.ncbi.nlm.nih.gov/2808985Surgical management of multiple ventricular septal defects.
J K Kirklin, A R Castaneda, J F Keane...
https://pubmed.ncbi.nlm.nih.gov/7421283